Table 1.
Patients’ characteristics
| Characteristics | Number of patients (n=39) | % |
|---|---|---|
| Age (years) | Median 47 (range, 28–72) | |
| Sex | ||
| Female | 8 | 20.5 |
| Male | 31 | 79.5 |
| ECOG performance status | ||
| 0 | 10 | 25.7 |
| 1 | 21 | 53.8 |
| 2 | 8 | 20.5 |
| Tumor involved site | ||
| Nasopharyngeal | 4 | 10.3 |
| Lymph node | 11 | 28.2 |
| Lung | 25 | 64.1 |
| Liver | 10 | 25.7 |
| Bone | 6 | 15.4 |
| Number of involved sites | ||
| 1 | 28 | 71.8 |
| 2 | 12 | 30.7 |
| 3 | 5 | 12.8 |
| Initial received platinum-based chemotherapy for recurrence/metastases | ||
| Cisplatin + 5-fluorouracil | 6 | 15.4 |
| Cisplatin + gemcitabine | 18 | 46.2 |
| Cisplatin + docetaxel | 12 | 30.7 |
| Cisplatin + paclitaxel | 8 | 20.5 |
| Carboplatin + paclitaxel | 10 | 25.7 |
| Number of chemotherapy regimens received | ||
| 1 | 13 | 33.3 |
| 2 | 20 | 51.3 |
| 3 | 6 | 15.4 |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.